PRINCETON JUNCTION, N.J., Nov. 22 /PRNewswire/ -- Imaging software company
EDDA Technology announced that it has received clearance from the U.S. Food
and Drug Administration (FDA) to market its debut product, IQQA(R)-Chest
software, an image analysis system that is specifically tailored for the
softcopy review of digital chest radiographic images.
The IQQA(R)-Chest software carries the CE mark, and was also cleared by
the Chinese State Food and Drug Administration for marketing and production in
October 2004.
IQQA(R)-Chest is the first real-time interactive diagnostic analysis
system, offering comprehensive tools not only for the identification but also
for the quantification of nodules detected with projection chest radiography,
the most commonly performed imaging procedure. In identifying nodules,
physicians are able to use lesion-specific image enhancement viewing (LSEV)
modes that dynamically detail image structures and highlight suspicious areas
suggesting nodular abnormalities. Once suspect nodules are identified, the
software offers regional analysis tools for the quantification of lesion
characteristics including size, density and shape.
Combining lesion-specific image enhancement viewing and ROI (region of
interest) evaluation tools, the software is designed to help radiologists with
the identification, confirmation and quantification of pulmonary lesions. The
software offers DICOM connectivity and automatically assembles diagnostic
information into a clinical report for referring physicians and follow-up
review. The "plug-and-play" software runs on standard PC platform.
"EDDA's vision is to seamlessly integrate advanced diagnostic analysis
technology into physicians' softcopy reading process for improved workflow and
clinical decision making," said Jian-Zhong Qian, Ph.D., president and CEO of
EDDA Technology. "Bridging the detection of pulmonary nodules with accurate
characterization, IQQA(R)-Chest bolsters the image quality and workflow
efficiency advantages of thoracic digital X-Ray. This combination will have a
broad impact on improving nodule case diagnosis and patient prognosis,
especially as digital X-Ray continues to gain market acceptance and
acceleration."
Lung cancer is the leading cause of cancer death among both men and women
in the United States and worldwide. According to the American Cancer Society
(ACS), there will be an estimated 160,440 deaths from lung cancer in the US in
2004. More people die of lung cancer than of colon, breast, and prostate
cancers combined. When lung cancer is found and treated in the earliest
stages, the average five-year survival rate is nearly 50 percent. However,
only 16 percent of lung cancer cases are diagnosed at this early, localized
stage.
A clinical study presented last month at the 11th International
Conference on Screening for Lung Cancer in Rome, Italy, demonstrated that the
IQQA(R)-Chest software helps to reduce inter-observer variation and to
improve the detection rate of actionable nodules, especially small nodules
(5-15mm) that are more likely to be overlooked. Conducted by Dr. Wei Song and
Dr. Zhenyu Jin at the Peking Union Medical College Hospital in Beijing, China,
the study involved the review of 232 chest DR cases from screening patients by
physicians of different experience levels.
About EDDA Technology
EDDA Technology, Inc. is a clinical computer solution provider in
diagnostic imaging and analysis. EDDA offers a series of new generation
software products to enable early detection of diseases and enhance precision
in diagnosis. EDDA's goal is to deliver advanced information analysis
technologies that improve clinical workflow and accuracy. A privately held
Delaware corporation, EDDA is headquartered in Princeton Junction, New Jersey,
and has a regional office in Shanghai, China. For more information, please
contact info@eddatech.com or call 609-936-8282.
Editor's Note: EDDA Technology will be exhibiting the IQQA(R)-Chest
software in the Mobile Computing Pavilion booth #1440 (Insight Sciences.com)
at the 90th Scientific Assembly and Annual Meeting of the Radiological Society
of North America (RSNA), Nov. 28 - Dec. 2, 2004.
SOURCE EDDA Technology, Inc.
 back to top
Related links:
http://www.eddatech.com
CONTACT:
Xiaolan Zeng, Ph.D. of EDDA Technology, Inc.,
+1-609-936-8282, or xzeng@eddatech.com
|
